Qube Research & Technologies (QRT)
SYRE icon

Qube Research & Technologies (QRT)’s Spyre Therapeutics SYRE Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio SYRE Stock Details SYRE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-12,672
Closed -$298K – 4084
2024
Q2 		$298K Sell
12,672
-45,006
-78% -$1.52M ﹤0.01% 2306
2024
Q1 		$2.19M Buy
+57,678
New +$1.67M ﹤0.01% 1703
2022
Q4 		– Sell
-1,459
Closed -$19K – 2980
2022
Q3 		$19K Sell
1,459
-179
-11% -$2.21K ﹤0.01% 2306
2022
Q2 		$21K Buy
+1,638
New +$57.4K ﹤0.01% 2260
2020
Q3 		– Sell
-1,444
Closed -$334K – 2096
2020
Q2 		$334K Buy
+1,444
New +$275K ﹤0.01% 1253

Other funds holding SYRE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Qube Research & Technologies (QRT)'s SYRE Position: Q3 2024 in Review

Qube Research & Technologies (QRT) sold out of Spyre Therapeutics (SYRE) in Q3 2024, closing a stake of 12,672 shares — an estimated $298K sold.

Qube Research & Technologies (QRT) first reported a position in SYRE in Q2 2020 and held it in 5 quarters. The position peaked at $2.19M in Q1 2024. 119 funds tracked by Wall St. Rank hold SYRE as of Q3 2024.

  • Qube Research & Technologies (QRT) reported no remaining Spyre Therapeutics position as of Q3 2024 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 12,672 Spyre Therapeutics shares in Q3 2024, an estimated $298K.
  • Qube Research & Technologies (QRT) first reported a position in Spyre Therapeutics in Q2 2020 and held it in 5 quarters.
  • Qube Research & Technologies (QRT)'s Spyre Therapeutics position peaked at $2.19M in Q1 2024.
  • 119 funds tracked by Wall St. Rank held Spyre Therapeutics as of Q3 2024.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q3 2024, filed 14 Nov 2024.